end stage renal disease
Conditions
Interventions
HFR Group:treatment of HFP
Hemofiltration Group:Hemofiltration therapy
Sponsors
Department of Nephrology, the Second Affiliated Hospital of Soochow University
Eligibility
Sex/Gender
All
Age
25 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Patients with uremia and maintenance HD in the Second Affiliated Hospital of Suzhou University were selected from January 2021 to December 2021; 2.There were restless legs itchy skin, intractable hypotension, poor sleep quality, personality variation, renal osteopathy and other long-term dialysis complications; 3.The patients received the standard dialysis protocol set by our center (dialysis 3 times a week,including 2 HD and 1 HDF for 6 months); 4.Blood samples were collected before and after treatment for inter group and self control.
Exclusion criteria
Exclusion criteria: 1.Patients with severe heart and liver diseases, pregnancy and severe acute infection were excluded; 2.Patients who did not timely review the relevant indicators and record the complications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whole blood parathyroid hormone(PTH);Homocysteine;ß2-MG;Restless legs syndrome research evaluation scale;Pittsburgh sleep quality index, PSQI; | — |
Countries
China
Contacts
Public ContactSong Kai
Department of Nephrology, the Second Affiliated Hospital of Soochow University
Outcome results
None listed